Home > Qtrly Results > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Quarterly Results Analysis [Sep2024]

GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
Audited
Dec2023
Audited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹507 Cr ₹589 Cr ₹537 Cr ₹573 Cr ₹595 Cr ₹578 Cr ₹621 Cr ₹541 Cr
Expenses ₹373 Cr ₹429 Cr ₹395 Cr ₹400 Cr ₹428 Cr ₹385 Cr ₹415 Cr ₹395 Cr
Operating Income ₹134 Cr ₹159 Cr ₹141 Cr ₹173 Cr ₹167 Cr ₹193 Cr ₹206 Cr ₹145 Cr
Other Income ₹9 Cr ₹5 Cr ₹3 Cr ₹2 Cr ₹5 Cr ₹2 Cr ₹3 Cr ₹7 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹15 Cr ₹14 Cr ₹15 Cr ₹13 Cr ₹13 Cr ₹13 Cr ₹12 Cr ₹11 Cr
Profit Before Tax ₹127 Cr ₹150 Cr ₹130 Cr ₹161 Cr ₹159 Cr ₹182 Cr ₹198 Cr ₹141 Cr
Profit After Tax ₹95 Cr ₹111 Cr ₹98 Cr ₹119 Cr ₹119 Cr ₹135 Cr ₹146 Cr ₹105 Cr
EPS ₹7.78 ₹9.10 ₹7.99 ₹9.69 ₹9.69 ₹11.05 ₹11.95 ₹8.57
Industry Peers & Returns1W1M1Y
GLENMARK LIFE SCIENCES -2.9% 0.4% 72.6%
SUN PHARMACEUTICAL INDUSTRIES 1.7% -4.7% 48.8%
CIPLA -0.9% -1.7% 17.3%
DR REDDYS LABORATORIES -1% -8.9% 6.5%
ZYDUS LIFESCIENCES -1% -4% 48.4%
DIVIS LABORATORIES 4.4% 3.1% 66%
MANKIND PHARMA -2.1% -0.6% 33.1%
TORRENT PHARMACEUTICALS 2.2% -5% 49.1%
LUPIN 2.8% -2.9% 70.8%

GLENMARK LIFE SCIENCES Quarterly Revenues

Revenues
Q-o-Q

-13.89 %

Y-o-Y

-14.86 %

Quarters Revenues % Change
Sep2024 ₹507 Cr
-13.89
Jun2024 ₹589 Cr
9.69
Mar2024 ₹537 Cr
-6.32
Dec2023 ₹573 Cr
-3.79
Sep2023 ₹595 Cr
2.92
Jun2023 ₹578 Cr
-6.90
Mar2023 ₹621 Cr
14.90
Dec2022 ₹541 Cr -

GLENMARK LIFE SCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

-15.75 %

Y-o-Y

-19.59 %

Quarters Operating Profit % Change
Sep2024 ₹134 Cr
-15.75
Jun2024 ₹159 Cr
12.75
Mar2024 ₹141 Cr
-18.03
Dec2023 ₹173 Cr
3.27
Sep2023 ₹167 Cr
-13.50
Jun2023 ₹193 Cr
-6.43
Mar2023 ₹206 Cr
41.92
Dec2022 ₹145 Cr -
Operating Margins
Q-o-Q

-2.14 %

Y-o-Y

-5.52 %

Quarters Operating Margin% % Change
Sep2024 26.51%
-2.14
Jun2024 27.09%
2.77
Mar2024 26.36%
-12.48
Dec2023 30.12%
7.34
Sep2023 28.06%
-15.96
Jun2023 33.39%
0.51
Mar2023 33.22%
23.49
Dec2022 26.9% -

GLENMARK LIFE SCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-14.50 %

Y-o-Y

-19.73 %

Quarters Profit After Tax % Change
Sep2024 ₹95 Cr
-14.50
Jun2024 ₹111 Cr
13.83
Mar2024 ₹98 Cr
-17.54
Dec2023 ₹119 Cr
0.02
Sep2023 ₹119 Cr
-12.34
Jun2023 ₹135 Cr
-7.45
Mar2023 ₹146 Cr
39.40
Dec2022 ₹105 Cr -
PAT Margins
Q-o-Q

-0.74 %

Y-o-Y

-5.72 %

Quarters PAT Margin(%) % Change
Sep2024 18.8 %
-0.74
Jun2024 18.94 %
3.78
Mar2024 18.25 %
-11.96
Dec2023 20.73 %
3.96
Sep2023 19.94 %
-14.86
Jun2023 23.42 %
-0.59
Mar2023 23.56 %
21.32
Dec2022 19.42 % -

GLENMARK LIFE SCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-14.51 %

Y-o-Y

-19.71 %

Quarters EPS % Change
Sep2024 ₹7.78
-14.51
Jun2024 ₹9.1
13.89
Mar2024 ₹7.99
-17.54
Dec2023 ₹9.69
0.00
Sep2023 ₹9.69
-12.31
Jun2023 ₹11.05
-7.53
Mar2023 ₹11.95
39.44
Dec2022 ₹8.57 -

You may also like the below Video Courses